-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 18, Alligator Bioscience announced that the company has signed a research cooperation and licensing agreement with Finland-based Orion Corporation (Orion) to jointly discover and develop new bispecific antibodies (bi-antibody) cancers Therapy
This research collaboration will focus on the discovery of novel bispecific antibodies on the immuno-oncology targets selected by Orion
Source: Alligator Bioscience official website
Reference materials:
[1] Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation.
(The original text has been deleted)